Chapter

Pharmaceuticals: Takeda, Merck

William V. Rapp

in Information Technology Strategies

Published in print August 2002 | ISBN: 9780195148138
Published online October 2011 | e-ISBN: 9780199849376 | DOI: http://dx.doi.org/10.1093/acprof:oso/9780195148138.003.0006
Pharmaceuticals: Takeda, Merck

Show Summary Details

Preview

Pharmaceuticals, as this accounts for a large part of health care, is provided with heavy regulation especially in high-income economies for the safety and costs of its clients. Firms who participate in this industry can earn profit despite cost minimization because some drugs may be more effective that other available treatments. The two significant aspects involved in the pharmaceuticals industry are the technological changes that arise from improvements in life and biological life sciences, and the political aspect. In line with proposed budget cuts and other political pressures, lawmakers and regulators are trying to come up with ways to lower health-care costs. IT plays no small part in this industry because cost determination and assessing the effectiveness of drugs involves IT-intensive processes which firms from other industries may also utilize. This chapter discusses the specific case of Takeda, a Level 2 IT user, and Merck, a Level 3 IT user.

Keywords: pharmaceuticals; regulation; cost determination; therapeutic effectiveness; IT-intensive processes; Takeda; Merck

Chapter.  15336 words. 

Subjects: Knowledge Management

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.